NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Structural Changes and Aggregation Mechanisms for Anti-Streptavidin IgG1 at Elevated Concentration
Published
Author(s)
Gregory V. Barnett, Wei Qi, Samiul Amin, E. Neil Lewis, Vladimir I. Razinkov, Bruce A. Kerwin, Yun Liu, Christopher J. Roberts
Abstract
Non-native protein aggregation may occur during manufacturing and storage of protein therapeutics, and this may decrease drug efficacy or jeopardize patient safety. From a regulatory perspective, changes in higher-order structure due to aggregation are of particular interest, but can be difficult to monitor directly at elevated protein concentrations. The present report focuses on non-native aggregation of anti-streptavidin (AS)IgG1 at 30 mg/mL under solution conditions that prior work at dilute concentrations (e.g. 1 mg/mL) indicated would result in different aggregation mechanisms. Time-dependent aggregation and structural changes were monitored in-situ with dynamic light scattering, small-angle neutron scattering, and Raman scattering; and ex-situ with far-UV circular dichroism and second Derivative UV spectroscopy. The effects of adding 0.15 M (5 w/w %) sucrose were also assessed. The addition of sucrose decreased monomer loss rates, but did not change protein-protein interactions, aggregation mechanism(s), or aggregate structure and morphology. Consistent with prior results, altering the pD or salt concentration had the primary effect of changing the aggregation mechanism. Overall, the results provide a comparison of aggregate structure and morphology created via different growth mechanisms using orthogonal techniques, and show that the techniques agree at least qualitatively. Interestingly, AS-IgG1 aggregate3s created at a pD 5.3 with no added salt formed the smallest aggregates, but had the largest structural changes compared to other solution conditions. The observation that the larger aggregates were also those with less structural perturbation compared to folded AS-IgG1 might be expected to extend to other proteins if the same strong electrostatic repulsions that mediate aggregate growth also mediate structural changes of the constituent proteins within aggregates.
Protein Aggregation, Protein Structure, Aggregate Mechanism, Aggregate Morphology
Citation
Barnett, G.
, Qi, W.
, Amin, S.
, Lewis, E.
, Razinkov, V.
, Kerwin, B.
, Liu, Y.
and Roberts, C.
(2015),
Structural Changes and Aggregation Mechanisms for Anti-Streptavidin IgG1 at Elevated Concentration, Journal of Physical Chemistry B, [online], https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=919844
(Accessed October 7, 2025)